Literature DB >> 11416865

Hypomorphic phenotype in mice with pituitary-specific knockout of steroidogenic factor 1.

L Zhao, M Bakke, Y Krimkevich, L J Cushman, A F Parlow, S A Camper, K L Parker.   

Abstract

The bacteriophage Cre recombinase provides a powerful approach for tissue-specific gene inactivation. Using a Cre transgene driven by the common alpha subunit of glycoprotein hormones (alphaGSU-Cre), we have previously inactivated steroidogenic factor 1 (SF-1) in the anterior pituitary, causing hypogonadotropic hypogonadism with sexual infantilism, sterility, and severe gonadal hypoplasia. We now explore the molecular mechanisms underlying a hypomorphic gonadal phenotype in mice carrying two floxed SF-1 alleles (F/F) relative to mice carrying one recombined and one floxed allele (F/R). Because their Cre-mediated disruption of the locus encoding SF-1 was less efficient, alphaGSU-Cre, F/F mice retained some gonadotropin-expressing cells in the anterior pituitary, thereby stimulating some gonadal function. This novel in vivo model for exploring the effects of differing levels of gonadotropins on gonadal development highlights the need for careful genotype-phenotype comparisons in studies using Cre recombinase to produce tissue-specific knockouts.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11416865     DOI: 10.1002/gene.1034

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  11 in total

Review 1.  Endocrine pathology in translational medicine: an overview of current and future prospects.

Authors:  Robert Yoshiyuki Osamura; Nobue Kumaki; Hiroshi Kajiwara; Noboru Egashira; Syunsuke Miyai; Susumu Takekoshi; Masanori Yasuda; Shinobu Umemura
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

2.  Pitx2 deletion in pituitary gonadotropes is compatible with gonadal development, puberty, and fertility.

Authors:  Michael A Charles; Amanda H Mortensen; Mary Anne Potok; Sally A Camper
Journal:  Genesis       Date:  2008-10       Impact factor: 2.487

Review 3.  Molecular mechanisms of pituitary organogenesis: In search of novel regulatory genes.

Authors:  S W Davis; F Castinetti; L R Carvalho; B S Ellsworth; M A Potok; R H Lyons; M L Brinkmeier; L T Raetzman; P Carninci; A H Mortensen; Y Hayashizaki; I J P Arnhold; B B Mendonça; T Brue; S A Camper
Journal:  Mol Cell Endocrinol       Date:  2009-12-16       Impact factor: 4.102

Review 4.  Welcoming beta-catenin to the gonadotropin-releasing hormone transcriptional network in gonadotropes.

Authors:  Travis B Salisbury; April K Binder; John H Nilson
Journal:  Mol Endocrinol       Date:  2008-01-24

5.  GnRH-regulated expression of Jun and JUN target genes in gonadotropes requires a functional interaction between TCF/LEF family members and beta-catenin.

Authors:  Travis B Salisbury; April K Binder; Jean C Grammer; John H Nilson
Journal:  Mol Endocrinol       Date:  2009-01-08

6.  Steroidogenic factor 1 differentially regulates fetal and adult leydig cell development in male mice.

Authors:  Tatiana Karpova; Kumarasamy Ravichandiran; Lovella Insisienmay; Daren Rice; Valentine Agbor; Leslie L Heckert
Journal:  Biol Reprod       Date:  2015-08-12       Impact factor: 4.285

7.  In vivo evidence for the crucial role of SF1 in steroid-producing cells of the testis, ovary and adrenal gland.

Authors:  F William Buaas; Jennifer R Gardiner; Sally Clayton; Pierre Val; Amanda Swain
Journal:  Development       Date:  2012-11-07       Impact factor: 6.868

Review 8.  Complex assembly on the human CYP17 promoter.

Authors:  Marion B Sewer; Srinath Jagarlapudi
Journal:  Mol Cell Endocrinol       Date:  2008-10-19       Impact factor: 4.102

Review 9.  Genetic regulation of murine pituitary development.

Authors:  Karine Rizzoti
Journal:  J Mol Endocrinol       Date:  2015-01-13       Impact factor: 5.098

10.  SF-1 a key player in the development and differentiation of steroidogenic tissues.

Authors:  Pierre Val; Anne-Marie Lefrançois-Martinez; Georges Veyssière; Antoine Martinez
Journal:  Nucl Recept       Date:  2003-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.